scholarly journals Prognostic value of cartilage intermediate layer protein 1 in chronic heart failure

2021 ◽  
Author(s):  
Can Wang ◽  
Wen Jian ◽  
Qiuhu Luo ◽  
Jiasheng Cui ◽  
Yali Qing ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Intermediate Layer ◽  
Prognostic Value

674 Prognostic value of androgens in male patients with chronic heart failure

2007 ◽  
Vol 6 (1) ◽  
pp. 146-147
Author(s):  
S STOERK ◽  
G GUEDER ◽  
S FRANTZ ◽  
J BAUERSACHS ◽  
D WEISMANN ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Prognostic Value ◽  
Male Patients

scholarly journals Long-Term and Short-Term Prognostic Value of Circulating Soluble Suppression of Tumorigenicity-2 Concentration in Chronic Heart Failure: A Systematic Review and Meta-Analysis

Cardiology ◽  
2021 ◽  
pp. 1-8
Author(s):  
Guoqi Dong ◽  
Hao Chen ◽  
Hongru Zhang ◽  
Yihuang Gu
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Prognostic Value ◽  
Web Of Science ◽  
Meta Analysis ◽  
Short Term ◽  
Prisma Statement ◽  
All Cause Mortality ◽  
Increasing Risk

<b><i>Introduction:</i></b> Soluble suppression of tumorigenicity-2 (sST2) has been considered as a prognostic factor of cardiovascular disease. However, the prognostic value of sST2 concentration in chronic heart failure remains to be summarized. <b><i>Methods:</i></b> We searched PubMed, Embase, and Web of Science for eligible studies up to January 1, 2020. Data extracted from articles and provided by authors were used in agreement with the PRISMA statement. The endpoints were all-cause mortality (ACM), cardiovascular mortality (CVM)/heart failure-related hospitalization (HFH), and all-cause mortality (ACM)/heart failure-related readmission (HFR). <b><i>Results:</i></b> A total of 11 studies with 5,121 participants were included in this analysis. Higher concentration of sST2 predicted the incidence of long-term ACM (hazard ratio [HR]: 1.03, 95% confidence interval [CI]: 1.02–1.04), long-term ACM/HFR (HR: 1.42, CI: 1.27–1.59), and long-term CVM/HFH (HR: 2.25, CI: 1.82–2.79), regardless of short-term ACM/HFR (HR: 2.31, CI: 0.71–7.49). <b><i>Conclusion:</i></b> Higher sST2 concentration at baseline is associated with increasing risk of long-term ACM, ACM/HFR, and CVM/HFH and can be a tool for the prognosis of chronic heart failure.

scholarly journals Prognostic value of serial six-minute walk tests using tele-accelerometry in patients with chronic heart failure: A pre-specified sub-study of the TIM-HF-Trial

2016 ◽  
Vol 23 (2_suppl) ◽  
pp. 21-26 ◽  
Author(s):  
Sandra Prescher ◽  
Christoph Schoebel ◽  
Kerstin Koehler ◽  
Oliver Deckwart ◽  
Brunhilde Wellge ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Prognostic Value ◽  
Minute Walk ◽  
Walk Tests
Sign in / Sign up

Export Citation Format

Share Document